Search Results

Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won

Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won

Industry News Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim

because the target is wrong—but because the chemical matter  interacting with that target lacks the right

Acting on the right signals today prevents tomorrow’s delays—and puts you ahead when budgets and timelines

Watch Episode 172 What happens when the career you planned no longer feels right?

The future of discovery will belong to scientists who know how to build the right partnerships and stay

Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals Are GLP-1s finding the right

directly to the researchers who use them , empowering scientists to move their work forward with the right

Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won

Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won

Without a reversal agent for xylazine, the best defense right now is mechanistic understanding .

Rodriguez, P.J., et al., Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

That's right, all the tidbits below will be for Premium Members ' eyes only.

It communicates that you know who you’re building for, why now is the right time, and how your solution

Bioscience Announces Site Relocation AI can help to speed up drug discovery — but only if we give it the right

Our scientific team can guide you choose or design the right fluorescent ligand for your research.  

Officer Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights

Fragment-Based Design, Synthesis, and Characterization of Aminoisoindole-Derived Furin Inhibitors A Bright

Or the right things are moving in the wrong order. 👉 That’s how biotech teams burn through capital without

At one point, he even questioned whether research was the right career for him.

News from November 25th to December 1st, 2024 Industry News Amgen says obesity drug caused up to 20% weight

The most used probe right now is the radioactive CP-55940, [3H-CP-55940].[11] Figure 1.

Right: Orion ligand analogs are engineered to optimize transmembrane domain providing significantly increased